Gene Expression Profiles in Stage II and III Colon Cancer. Application of a 128-gene signature

Download

Purpose: A 128-gene signature has been proposed to predict poor outcomes in patients with stage II and III colorectal cancer. In the present study we aimed to validate this previously published 128-gene signature on external and independent data from patients with stage II and III colon cancer.

Cancer Type: Colorectal Cancer

GPL: 570

Number of Genes with Data: 978

Number Observations: 37

Number Outputs: 2

Imbalanced Ratio: 0.608695652

Default Task: Classification